News Headlines Article

FDA says benefits outweigh risks of endoscope use tied to superbug infections
Modern Healthcare

The U.S. Food and Drug Administration on Wednesday advised health providers not to cancel surgical procedures involving the use of medical endoscopes. Endoscopes have been linked to drug-resistant superbug outbreaks at two California hospitals in recent months, but the FDA said the benefits of performing such procedures still outweigh the potential risks.The FDA stated Wednesday that it was not recommending hospitals begin canceling endoscopic retrograde cholangiopancreatography, or ERCP, for patients who need the procedure.